Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guanylate cyclase in human platelets with different aggregability.

Chirkov YuYu1, I A Tyshchuk, I S Severina

  • 1Institute of Biological and Medical Chemistry, USSR Academy of Medical Sciences, Moscow.

Experientia
|July 15, 1990
PubMed
Summary

Platelets from diabetes mellitus patients show reduced guanylate cyclase activity and increased aggregation. These anomalies are more severe in type II than type I diabetes, impacting blood clotting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The history of renalase from amine oxidase to a a-NAD(P)H-oxidase/anomerase].

Biomeditsinskaia khimiia·2015
Same author

[Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives].

Biomeditsinskaia khimiia·2015
Same author

[Potentiation of NO-dependent activation of soluble guanylyl cyclase by 5-nitroisatin and antiviral preparatation arbidol].

Biomeditsinskaia khimiia·2013
Same author

[Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs].

Biomeditsinskaia khimiia·2012
Same author

[Inhibition of no-dependent soluble human platelet guanylate cyclase by isatin].

Biomeditsinskaia khimiia·2011
Same author

[Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].

Biomeditsinskaia khimiia·2009

Area of Science:

  • Biochemistry
  • Hematology
  • Endocrinology

Background:

  • Diabetes mellitus is associated with vascular complications.
  • Platelet function plays a critical role in hemostasis and thrombosis.
  • Guanylate cyclase is an enzyme involved in regulating platelet activity.

Purpose of the Study:

  • To investigate the activity of human platelet guanylate cyclase in diabetes mellitus patients.
  • To assess the activation of guanylate cyclase by sodium nitroprusside in diabetic platelets.
  • To correlate guanylate cyclase activity and platelet aggregability with diabetes type.

Main Methods:

  • Platelet isolation from patients with type I and type II diabetes mellitus and healthy controls.
  • Measurement of basal and sodium nitroprusside-stimulated guanylate cyclase activity.

Related Experiment Videos

  • Assessment of adenosine diphosphate (ADP)-induced platelet aggregation.

    • Main Results:

    • Decreased guanylate cyclase activity and impaired enzyme activation by sodium nitroprusside were observed in platelets from diabetes mellitus patients.
    • Platelets from diabetic patients exhibited increased aggregability.
    • Anomalies in guanylate cyclase activity and ADP-induced aggregation were more pronounced in type II diabetes compared to type I diabetes.

    Conclusions:

    • Diabetes mellitus is characterized by impaired platelet guanylate cyclase function and altered platelet aggregation.
    • These functional platelet abnormalities may contribute to the increased thrombotic risk in diabetes.
    • The severity of platelet dysfunction correlates with diabetes type, suggesting distinct pathophysiological mechanisms.